Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Laboratory Evaluation of Resveratrol Loaded Nanoparticles in the Treatment of Periodontitis: A Randomized Controlled Clinical Trial

NCT07397026 is registered in ClinicalTrials.gov with Hagar Ahmed Ali Mohammed Elzain as lead sponsor.

NCT NCT07397026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07397026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Laboratory Evaluation of Resveratrol Loaded Nanoparticles in the Treatment of Periodontitis: A Randomized Controlled Clinical Trial
Lead sponsor
Hagar Ahmed Ali Mohammed Elzain
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 9, 2025
Completion date
April 1, 2026
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

periodontitis stage iii